TY - JOUR
T1 - Risk Score Model for Predicting Mortality in Advanced Heart Failure Patients Followed in a Heart Failure Clinic
AU - Zafrir, Barak
AU - Goren, Yaron
AU - Paz, Hagar
AU - Wolff, Rafael
AU - Salman, Nabia
AU - Merhavi, Dina
AU - Lavi, Idit
AU - Lewis, Basil S.
AU - Amir, Offer
PY - 2012/9
Y1 - 2012/9
N2 - The prevalence of heart failure (HF) in the population is increasing, concomitant with high incidence of rehospitalizations and mortality. The aim of this study was to characterize a prognostic risk score model for patients with chronic HF. A total of 500 patients followed at the HF clinic were evaluated by clinical, functional, laboratory, imaging, and therapeutic variables that were correlated to mortality during a follow-up period of 25months. Risk stratification was carried out by applying a risk score model based on multivariate analysis. Predictors correlated with mortality during follow-up were systolic blood pressure <110mmHg, male sex, age older than 70years, 6-minute walk distance <300m, lack of β-blocker therapy, hyperuricemia (>7.5mg/dL), hyponatremia, and prolonged QTc interval (>450ms). Based on these variables, a risk score model (score 0-55) was established and included low risk, score <21 (9% mortality during 2-year follow-up); moderate risk, 21 to 29 (22%); high risk, 30 to 35 (35%), and very high risk: ≥36 points (62% 2-year mortality). The risk model had good discrimination ability (concordance index 0.75), which was better than the performance of the Seattle Heart Failure Model on our cohort (0.69). Simple noninvasive characteristics examined during the initial admission to the HF clinic can serve as prognostic markers for mortality and may help in the process of therapeutic decision-making in patients with HF.
AB - The prevalence of heart failure (HF) in the population is increasing, concomitant with high incidence of rehospitalizations and mortality. The aim of this study was to characterize a prognostic risk score model for patients with chronic HF. A total of 500 patients followed at the HF clinic were evaluated by clinical, functional, laboratory, imaging, and therapeutic variables that were correlated to mortality during a follow-up period of 25months. Risk stratification was carried out by applying a risk score model based on multivariate analysis. Predictors correlated with mortality during follow-up were systolic blood pressure <110mmHg, male sex, age older than 70years, 6-minute walk distance <300m, lack of β-blocker therapy, hyperuricemia (>7.5mg/dL), hyponatremia, and prolonged QTc interval (>450ms). Based on these variables, a risk score model (score 0-55) was established and included low risk, score <21 (9% mortality during 2-year follow-up); moderate risk, 21 to 29 (22%); high risk, 30 to 35 (35%), and very high risk: ≥36 points (62% 2-year mortality). The risk model had good discrimination ability (concordance index 0.75), which was better than the performance of the Seattle Heart Failure Model on our cohort (0.69). Simple noninvasive characteristics examined during the initial admission to the HF clinic can serve as prognostic markers for mortality and may help in the process of therapeutic decision-making in patients with HF.
UR - https://www.scopus.com/pages/publications/84866538195
U2 - 10.1111/j.1751-7133.2012.00286.x
DO - 10.1111/j.1751-7133.2012.00286.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22994439
AN - SCOPUS:84866538195
SN - 1527-5299
VL - 18
SP - 254
EP - 261
JO - Congestive Heart Failure
JF - Congestive Heart Failure
IS - 5
ER -